611
Views
24
CrossRef citations to date
0
Altmetric
Review Article

Acrodermatitis continua of Hallopeau (ACH): Two cases successfully treated with adalimumab

, , , &
Pages 489-494 | Received 27 Jun 2013, Accepted 05 Sep 2013, Published online: 12 Nov 2013

References

  • Waller JM, Wu JJ, Murase JE, et al. Chronically painful right thumb with pustules and onycholysis. Diagnosis: acrodermatitis continua of Hallopeau. Clin Exp Dermatol. 2007;32:619–20
  • Nikkels AF, Nikkels-Tassoudji N, Pierard GE. Breaking the relentless course of Hallopeau’s acrodermatitis by dapsone. Eur J Dermatol. 1999;9:126–8
  • Balato N, Gallo L, Balato A, et al. Acrodermatitis continua of Hallopeau responding to efalizumab therapy. JEADV. 2009;23:1327–49
  • Mang R, Ruzicka T, Stege H. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-a inhibitor infliximab. Br J Dermatol. 2004;150:379–80
  • Adisen E, Öztas M, Gürer MA. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau. Int J Dermatol. 2007;46:1205–7
  • Ryan C, Collins P, Kirby B, Rogers S. Treatment of acrodermatitis continua of Hallopaeau with adalimumab. Br J Dermatol. 2009;160:203–5
  • Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol. 2005;153:445–6
  • Calabrese LH. Molecular differences in anticytokine therapies. Clin Exp Rheumatol. 2003;21:241–8
  • Tavazzi E, Ferrante P, Khalili K. Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies. Clin Microbiol Infect. 2011;17:1776–80
  • Radcliff-Crocker H. Diseases of the Skin: Their Description, Pathology, Diagnosis and Treatment. London: H. K. Lewis, 1888
  • Hallopeau MH. Sur une asphyxie locale des extrémités avec polydactylite suppurative chronique et poussées éphémères de dermatite pustuleuse disséminée et symétrique. Bull Soc Fr Dermatol Syphiligr. 1890;1:39–45
  • Strandberg J. Acrodermatitis continua (Hallopeau). Acta Derm Venereol (Stockh). 1925;6:314–28
  • Ingram JT. Acrodermatitis perstans and its relation to psoriasis. Br J Dermatol. 1930;42:483–9
  • Lever WF. Acrodermatitis continua (Hallopeau): effect of treatment with sulfapyridine. Arch Dermatol Syphilol. 1944;49:273–7
  • Pearson LH, Allen BS, Smith JG Jr. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. J Am Acad Dermatol. 1984;11:755–62
  • Suchanek J. Relation of Hallopeau’s acrodermatitis continua to psoriasis. Przegl Dermatol. 1951;1:165–81
  • Tsukada S, Aikawa A. Some considerations on pathogenesis and treatment of acrodematitis continua suppurativa (Hallopeau). Tohoku J Exp Med. 1962;78:195–201
  • Kogoj F. Clinical and histological picture of acrodermatitis continua. Arch Dermatol Syph. 1951;193:417–33
  • White MI, Main RA. The treatment of Hallopeau’s acrodermatitis. Arch Dermatol. 1979;115:235–6
  • Piquero-Casals J, Fonseca de Mello AP, Dal Coleto C, et al. Using oral tetracycline and topical betamethasone valerate to treat acrodermatitis continua of hallopeau. Cutis. 2002;70:106–8
  • Notowicz A, Stolz E, Heuvel NV. Treatment of Hallopeau’s acrodermatitis with topical mechlorethamine. Arch Dermatol. 1978;114:129--30
  • Tsuji T, Nishimura M. Topically administered fluorouracil in acrodermatitis continua of Hallopeau. Arch Dermatol. 1991;127:27–8
  • Wilsmann-Theis D, Hagemann T, Dederer H, et al. Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol. 2004;150:1194–7
  • Sehgal VN, Verma P, Sharma S, et al. Acrodermatitis continua of Hallopeau: evolution of treatment options. Int J Derm. 2011;50:1195–211
  • Emtestam L, Wedén U. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol. Br J Dermatol. 1996;135:644–6
  • Piraccini BM, Tosti A, Iorizzo M, Misciali C. Pustular psoriasis of the nails: treatment and longterm follow-up of 46 patients. Br J Dermatol. 2001;144:1000–5
  • Mozzanica N, Cattaneo A. The clinical effect of topical calcipotriol in acrodermatitis continua of Hallopeau. Br J Dermatol. 1998;138:556
  • Kokelj F, Plozzer C, Trevisan G. Uselessness of topical calcipotriol as monotherapy for acrodermatitis continua of Hallopeau. Acta Derm Venereol. 2001;81:153
  • Kuijpers AL, van Dooren-Greebe RJ, van de Kerkhof PC. Acrodermatitis continua of Hallopeau: response to combined treatment with acitretin and calcipotriol ointment. Dermatology. 1996;192:357–9
  • Brill TJ, Elshorst-Schmidt T, Valesky EM, et al. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Dermatology. 2005;211:351--5
  • Brunasso AM, Lo Scocco G, Massone C. Recalcitrant acrodermatitis continua of hallopeau treated with calcitriol and tacrolimus 0.1% topical treatment. J Eur Acad Dermatol Venereol. 2008;22:1272--3
  • Sotiriadis D, Patsatsi A, Sotiriou E, et al. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate. J Dermatolog Treat. 2007;18:315--8
  • Behrens S, von Kobyletzki G, Hoffmann K, et al. PUVA-bath photochemotherapy in Hallopeau’s acrodermatitis continua suppurativa. Hautarzt. 1997;48:824–7
  • Durmazlar SP, Akpinar H, Eren C, et al. Treatment of acrodermatitis continua with topical 8-methoxypsoralen plus local narrowband ultraviolet B phototherapy. Eur J Dermatol. 2009;19:478–80
  • Kiszewski AE, De Villa D, Scheibel I, Ricachnevsky N. An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy. Pediatr Dermatol. 2009;26:105–6
  • Bordignon M, Zattra E, Albertin C, Belloni-Fortina A. Successful treatment of a 9-year-old boy affected by acrodermatitis continua of Hallopeau with targeted ultraviolet B narrow-band phototherapy. Photodermatol Photoimmunol Photomed. 2010;26:41–3
  • Harland CC, Kilby PE, Dalziel KL. Acrodermatitis continua responding to cyclosporin therapy. Clin Exp Dermatol. 1992;17:376–8
  • Chowdhury MM, Motley RJ. Treatment of acrodermatitis continua of Hallopeau with oral propylthiouracil and methotrexate. Clin Exp Dermatol. 2001;26:657–60
  • Zachariae H, Thestrup-Pedersen K. Cyclosporin A in acrodermatitis continua. Dermatologica. 1987;175:29–32
  • Baker H. Localized pustular psoriasis. In: Roenigk HH, Maibach HI, eds. Psoriasis. New York: Dekker, 1986. p 40–5
  • Slawsky LD, Libow LF. Successful treatment of acrodermatitis continua of Hallopeau with etretinate. J Am Acad Dermatol. 1990;23:1176–8
  • Van Dooren-Greebe RJ, van de Kerkhof PC, Chang A, Happle R. Acitretin monotherapy in acrodermatitis continua Hallopeau. Acta Derm Venereol. 1989;69:344–6
  • Van der Kerkhof PC, Steijlen PM, Raymakers RA. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome. Br J Dermatol. 1996;134:754–7
  • Rubio C, Martin MA, Arranz Sánchez DM, et al. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau. J Eur Aca Dermatol Venereol. 2009;23:707–8
  • Puig L, Barco D, Vilarrasa E, Alomar A. Treatment of acrodermatitis continua of Hallopeau with TNF blocking agents: case report and review. Dermatology. 2010;220:154–8
  • Kazinski K, Joyce KM, Hodson D. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of Hallopeau. J Drugs Dermatol. 2005;4:360–4
  • Silpa-archa N, Wongpraparut C. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept. J Med Assoc Thai. 2011;94:1154–7
  • Ahmad K, Rogers S. Two years of experience with etanercept in recalcitrant psoriasis. Br J Dermatol. 2007;156:1010–14
  • Adişen E, Oztaş M, Gürer MA. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau. Int J Dermatol. 2007;46:1205–7
  • Ahmad K, Rogers S. Three years’ experience with infliximab in recalcitrant psoriasis. Clin Exp Dermatol. 2006;31:630–3
  • Dini V, Barbanera S, Romanelli M. Efficacy of Adalimumab for the Treatment of Refractory Paediatric Acrodermatitis Continua of Hallopeau. Acta Derm Venereol. 2013 Feb 14. doi: 10.2340/00015555-1540
  • Sopkovich JA, Anetakis Poulos G, Wong HK. Acrodermatitis continua of hallopeau successfully treated with adalimumab. J Clin Aesthet Dermatol.  2012;5:60–2
  • Allegue F, Pardo J, Ruffin J, et al. Treatment of acrodermatitis continua of hallopeau with ustekinumab. J Eur Acad Dermatol Venereol. 2010;24(Suppl 4):1--83
  • Korstanje MJ, Bessems PJ, Hulsmans RF, et al. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A. Dermatologica. 1989;179:90--1
  • Peter RU, Ruzicka T, Donhauser G, et al. Acrodermatitis continua-type of pustular psoriasis responds to low-dose cyclosporine. J Am Acad Dermatol. 1990;23(3 Pt 1):515--6
  • Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol. 1990;126:339--50
  • Nikkels AF, Piérard GE. Etanercept and recalcitrant acrodermatitis continua of Hallopeau. J Drugs Dermatol. 2006;5:705--6
  • Bonish B, Rashid RM, Swan J. Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing? J Drugs Dermatol. 2006;5:903--4
  • Thielen AM, Barde C, Marazza G. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade). Dermatology. 2008;217:137--9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.